
    
      The objective of this study is to assess the efficacy and tolerance of a single cycle of
      rituximab in control of bullous pemphigoid.

      the main objects are :

        1. to assess that a single cycle of rituximab is able to control patient with
           corticosteroid-dependent bullous pemphigoid,

        2. to avoid the use of corticosteroid in long time,

        3. to evaluate duration of control disease and side effect with a single cycle of
           rituximab.
    
  